PF-07265803

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07265803, covering 2024-03-29 to 2024-03-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803 [Phase 1]